Literature DB >> 8836379

Noninvasive ultrasonic subtotal ablation of the prostate in dogs.

L F Kincaide1, N T Sanghvi, O Cummings, R Bihrle, R S Foster, A Zaitsev, M Phillips, J Syrus, C Hennige.   

Abstract

OBJECTIVE: To determine whether high-intensity focused ultrasound (HIFU) can be used for subtotal ablation of the prostate gland in dogs without causing damage to surrounding tissues.
DESIGN: Experimental trial. ANIMALS: Adult hounds > or = 5 years old and weighing between 20 and 30 kg. PROCEDURE: Prostatic ablation was performed in all dogs, using a transrectal HIFU probe. Acute effects of HIFU treatment were evaluated in 4 dogs. These dogs were euthanatized and necropsied 4 hours after the procedure. Chronic effects were evaluated in the other 3 dogs. Serial CBC, serum biochemical analyses, urinalyses, and transrectal ultrasonography were performed. Dogs were euthanatized and necropsied 3 months (1 dog) or 1 year (2 dogs) after HIFU treatment.
RESULTS: Histologic examination of the prostate glands from the 4 dogs euthanatized 4 hours after treatment revealed that 80 to 90% of the gland had undergone hemorrhagic, liquefactive necrosis. Only slight discoloration of the prostatic capsule was detected, and there were not any gross or histologic lesions of the rectal mucosa or urinary bladder. All 3 dogs followed up after HIFU treatment developed cystic cavities within the prostate. Clinicopathologic testing did not indicate any long-term adverse effects. CONCLUSIONS AND CLINICAL RELEVANCE: This method was effective in causing subtotal ablation of prostatic tissue in dogs. Further study of morbidity is required before the technique can be used clinically.

Entities:  

Mesh:

Year:  1996        PMID: 8836379

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors.

Authors:  Jian-Jun Li; Guo-Liang Xu; Mo-Fa Gu; Guang-Yu Luo; Zhang Rong; Pei-Hong Wu; Jian-Chuan Xia
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

2.  Sequential changes in rat femoral artery blood flow and tissue degeneration after exposure to high-intensity focused ultrasound.

Authors:  Tetsuya Ishikawa; Takashi Okai; Kazuaki Sasaki; Shin-Ichiro Umemura; Nozomi Miyazaki; Miki Kushima; Hiroko Aoki; Mitsuyoshi Ichihara; Kiyotake Ichizuka
Journal:  J Med Ultrason (2001)       Date:  2008-12-16       Impact factor: 1.314

3.  Correlation of contrast-enhanced MR images with the histopathology of minimally invasive thermal and cryoablation cancer treatments in normal dog prostates.

Authors:  D M Bouley; B Daniel; K Butts Pauly; E Liu; A Kinsey; W Nau; C J Diederich; G Sommer
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2007-02-08

Review 4.  Development and future prospective of treatment for localized prostate cancer with high-intensity focused ultrasound.

Authors:  Sunao Shoji; Norihiro Koizumi; Soichiro Yuzuriha; Tatsuo Kano; Takahiro Ogawa; Mayura Nakano; Masayoshi Kawakami; Masahiro Nitta; Masanori Hasegawa; Akira Miyajima
Journal:  J Med Ultrason (2001)       Date:  2022-01-15       Impact factor: 1.314

Review 5.  Thermal-based treatment options for localized prostate cancer.

Authors:  Michael O Koch; Thomas A Gardner
Journal:  Curr Treat Options Oncol       Date:  2005-09

Review 6.  Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance.

Authors:  Graham Sommer; Donna Bouley; Harcharan Gill; Bruce Daniel; Kim Butts Pauly; Chris Diederich
Journal:  Can J Urol       Date:  2013-04       Impact factor: 1.344

7.  Antitumor effect of microbubbles enhanced by low frequency ultrasound cavitation on prostate carcinoma xenografts in nude mice.

Authors:  Yu Wang; Bing Hu; Xuehong Diao; Jizhen Zhang
Journal:  Exp Ther Med       Date:  2011-11-07       Impact factor: 2.447

8.  Applicators for magnetic resonance-guided ultrasonic ablation of benign prostatic hyperplasia.

Authors:  Graham Sommer; Kim Butts Pauly; Andrew Holbrook; Juan Plata; Bruce Daniel; Donna Bouley; Harcharan Gill; Punit Prakash; Vasant Salgaonkar; Peter Jones; Chris Diederich
Journal:  Invest Radiol       Date:  2013-06       Impact factor: 6.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.